|
|
Volumn 16, Issue 4, 1998, Pages 319-345
|
|
Fosinopril: Emerging considerations and implications for angiotensin-converting enzyme inhibitor therapy
|
|
Author keywords
Accumulation index; Angiotensin converting enzyme inhibitors; Antiproteinuric; Cardiovascular morbidity and mortality; Congestive heart failure; Fosinopril; Hypertension; Pharmacokinetics
|
|
Indexed keywords
AMLODIPINE;
BENAZEPRIL;
CAPTOPRIL;
CHLORTALIDONE;
CILAZAPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRILAT;
FOSINOPRIL;
FOSINOPRILAT;
HYDROCHLOROTHIAZIDE;
ISRADIPINE;
LIPID;
LISINOPRIL;
MOEXIPRIL;
NIFEDIPINE;
PERINDOPRIL;
PROPRANOLOL;
QUINAPRIL;
RAMIPRIL;
THIAZIDE DIURETIC AGENT;
TRANDOLAPRIL;
VERAPAMIL;
BRAIN FUNCTION;
CONGESTIVE HEART FAILURE;
DIABETES MELLITUS;
DIASTOLIC BLOOD PRESSURE;
DRUG ACCUMULATION;
DRUG EFFICACY;
DRUG STRUCTURE;
GERIATRICS;
HEART INFARCTION;
HEART LEFT VENTRICLE HYPERTROPHY;
HEMODYNAMICS;
HUMAN;
HYPERTENSION;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY FUNCTION;
LIPID BLOOD LEVEL;
MATERNAL HYPERTENSION;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PEDIATRICS;
PRIORITY JOURNAL;
RAT;
REVIEW;
SYSTOLIC BLOOD PRESSURE;
|
|
EID: 0032470036
PISSN: 08975957
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1527-3466.1998.tb00362.x Document Type: Review |
|
Times cited : (6)
|
|
References (117)
|
